| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/17/1999 | CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | CA2312190A1 Glp-1 formulations |
| 06/17/1999 | CA2312049A1 Method for purifying heat shock peptides complexes |
| 06/17/1999 | CA2311681A1 Human interferon-epsilon: a type i interferon |
| 06/17/1999 | CA2311645A1 Gene family with transformation modulating activity |
| 06/17/1999 | CA2311295A1 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 06/17/1999 | CA2311283A1 Purification and microsequencing of hyaluronidase isozymes |
| 06/17/1999 | CA2311281A1 Cyp7 promoter-binding factors |
| 06/17/1999 | CA2309686A1 Composition useful for providing one-step surgical preparation and drape |
| 06/17/1999 | CA2256250A1 Method for enhancing an immune response using mitogenic and chemokinetic factors |
| 06/16/1999 | EP0922769A1 Iron-casein complex hydrolyzate and process for the production thereof |
| 06/16/1999 | EP0922768A2 Oncogene or virus-driven expression systems |
| 06/16/1999 | EP0922763A1 Inwardly rectifying potassium channel gene and protein |
| 06/16/1999 | EP0922762A1 Drug binding protein |
| 06/16/1999 | EP0922761A1 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 06/16/1999 | EP0922710A1 PEPTIDES PROMOTING THE ACTIVATION OF LATENT TGF-$g(b) AND METHOD FOR SCREENING TGF-$g(b) ACTIVITY REGULATORS |
| 06/16/1999 | EP0922455A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions |
| 06/16/1999 | EP0922454A2 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 06/16/1999 | EP0922446A1 Solution-phase site-specific preparation of GRF-PEG conjugates |
| 06/16/1999 | EP0922111A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 06/16/1999 | EP0922110A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 06/16/1999 | EP0922107A1 Human kallikrein |
| 06/16/1999 | EP0922105A2 Infectious papillomavirus pseudoviral particles |
| 06/16/1999 | EP0922103A1 NEW $i(BRUCELLA) ANTIGENS, RECOMBINANT POLYPEPTIDES, NUCLEIC ACIDS CODING FOR THE SAME AND USE THEREOF IN DIAGNOSTIC AND PROPHYLACTIC METHODS AND KITS |
| 06/16/1999 | EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 06/16/1999 | EP0922101A1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 06/16/1999 | EP0922100A2 Secreted proteins and polynucleotides encoding them |
| 06/16/1999 | EP0922099A1 Fas ligand-like protein, its production and use |
| 06/16/1999 | EP0922058A2 Self-aligning peptides derived from elastin and other fibrous proteins |
| 06/16/1999 | EP0922056A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 06/16/1999 | EP0922055A1 Conotoxin peptide pviia |
| 06/16/1999 | EP0922054A1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 06/16/1999 | EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR |
| 06/16/1999 | EP0921822A1 Animal model for transplantation |
| 06/16/1999 | EP0921821A1 2-methoxyestradiol-induced apoptosis in cancer cells |
| 06/16/1999 | EP0921820A1 Gene therapy for obesity |
| 06/16/1999 | EP0921819A1 Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin |
| 06/16/1999 | EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 06/16/1999 | EP0921817A1 Pegylation process |
| 06/16/1999 | EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 06/16/1999 | EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 06/16/1999 | EP0921812A1 INSULIN PREPARATIONS CONTAINING NaCl |
| 06/16/1999 | EP0921811A2 Administration of histamine for therapeutic purposes |
| 06/16/1999 | EP0921810A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
| 06/16/1999 | EP0921809A1 Use of prolactin as a tgf-beta antagonist |
| 06/16/1999 | EP0921808A1 Non-aqueous polar aprotic peptide formulations |
| 06/16/1999 | EP0921786A1 Nasal administration of desmopressin |
| 06/16/1999 | EP0921785A1 Combination of acid protease enzymes and acidic buffers and uses thereof |
| 06/16/1999 | EP0753003B1 Aziridine derivatives, their production and use |
| 06/16/1999 | EP0749582B1 Methods of diagnosing preeclampsia |
| 06/16/1999 | EP0711283B1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
| 06/16/1999 | EP0684830B1 Inhibitors of thrombosis |
| 06/16/1999 | EP0633764B1 Skin care method and composition |
| 06/16/1999 | EP0542934B1 Use of somatostatin analogues for treating melanomas |
| 06/16/1999 | EP0491828B1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 06/16/1999 | CN1219968A Antibodies to ED-8 domain of fibronectin, their construction and uses |
| 06/16/1999 | CN1219967A Glial cell line-derived neurotrophic factor receptor |
| 06/16/1999 | CN1219965A Promotion of regeneration of organized tissues |
| 06/16/1999 | CN1219939A Method and apparatus for preparing acellular red blood cell substitute |
| 06/16/1999 | CN1219938A Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 06/16/1999 | CN1219882A Concentrated antibody preparation |
| 06/16/1999 | CN1043647C Peptide compound |
| 06/15/1999 | US5912346 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 06/15/1999 | US5912337 Parasitic helminth p22U proteins |
| 06/15/1999 | US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease |
| 06/15/1999 | US5912327 Treating with low concentrations of chaotropic agents to solubilize protein, diluting solution with 10 to 20 volumes of buffer ph 4.5 to refold protein, recovering protein |
| 06/15/1999 | US5912325 A polypeptide which codes for an epitope of an animal growth hormone; animal growth enhancer |
| 06/15/1999 | US5912250 Use of immunosuppressive agents for the treatment of schizophrenia |
| 06/15/1999 | US5912241 Antiprotozoa agents |
| 06/15/1999 | US5912236 Broad-spectrum tumor suppressor genes gene products and methods for tumor suppressor gene therapy |
| 06/15/1999 | US5912234 Integrin-binding peptides |
| 06/15/1999 | US5912233 Methods and peptides for the treatment of non-IgE-mediated diseases |
| 06/15/1999 | US5912232 Administering peptides having antagonist activity for alpha chemokines, for treatment of autoimmune and inflammatory disorders |
| 06/15/1999 | US5912231 Substitution analogues of magainin peptides |
| 06/15/1999 | US5912230 Polypeptides with specified sequences |
| 06/15/1999 | US5912229 Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 06/15/1999 | US5912228 Mixture with ethylene oxide-propylene oxide block copolymer and ethylenediaminetetraacetic acid |
| 06/15/1999 | US5912227 Method of enhancing nutrient uptake |
| 06/15/1999 | US5912226 Antibiotic |
| 06/15/1999 | US5912224 Methods and compositions for enhancing cellular response to TGF-β ligands |
| 06/15/1999 | US5912183 Amino acid sequences with phosphorylated tyrosine which interact with intracellular signal transducers and interfere with signal transduction; antimetastasis/anticarcinogenic/ antitumor/antiproliferative agents |
| 06/15/1999 | US5912176 Antibodies against a host cell antigen complex for pre and post exposure protection from infection by HIV |
| 06/15/1999 | US5912171 Amino acid transporters and uses |
| 06/15/1999 | US5912170 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
| 06/15/1999 | US5912168 CD95 regulatory gene sequences |
| 06/15/1999 | US5912166 Compounds and methods for diagnosis of leishmaniasis |
| 06/15/1999 | US5912160 A protein invovled in tyrosine kinase activation pathway; antitumor and antidiabetic agents |
| 06/15/1999 | US5912159 An isolated human polypeptide which controls nitric oxide biosynthesis; diagnosis and therapy for urea cycle diseases, hypertension, hypotension, prostate cancer/ hyperplasia/ hypertrophy and kidney diseases |
| 06/15/1999 | US5912153 Fungicides which interfere with fungal wall assembly, hyphal growth and infection; nontoxic to humans |
| 06/15/1999 | US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents |
| 06/15/1999 | US5912143 Polynucleotides encoding a human mage protein homolog |
| 06/15/1999 | US5912142 Gene product over expressed in cancer cells |
| 06/15/1999 | US5912141 Nucleic acids encoding tumor virus susceptibility genes |
| 06/15/1999 | US5912138 Substrate trapping protein tyrosine phosphatases |
| 06/15/1999 | US5912136 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 06/15/1999 | US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology |
| 06/15/1999 | US5912121 Obtaining dna samples from patient coding for tropomyosin or cardiac troponin t proteins; determining if mutations are present; early, noninvasive, assymptomatic diagnosis |
| 06/15/1999 | US5912015 Drug delivery using time-release agent having zinc or magnesium salt dispersed in matrix; biodegradable |
| 06/15/1999 | US5912014 Oral salmon calcitonin pharmaceutical products |
| 06/15/1999 | US5912005 Methods of use of uncoated gel particles |